secwatch.observer — SEC 8-K summary
======================================

Issuer:     NOVAVAX INC (NVAX)
CIK:        0001000694
Form:       8-K
Filed at:   2025-06-24T23:59:59+00:00
Accession:  0001104659-25-061874
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Novavax stockholders elect directors, approve advisory compensation, ratify auditor at 2025 annual meeting
--------------------------------------------------------------------------------

- Elected Class III directors Rachel K. King, John W. Shiver, and Charles W. Newton (each with majority 'For' votes).
- Advisory vote on named executive officer compensation approved: 41,390,651 For, 15,830,308 Against.
- Ratification of Ernst & Young as auditor for FY2025 approved: 79,306,893 For, 15,057,873 Against.
- Quorum of 95,359,194 shares present; total outstanding shares were 161,968,503 as of record date April 21, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1000694/000110465925061874/0001104659-25-061874-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1000694/000110465925061874/tm2518733d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-061874

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer